Etiracetam: Difference between revisions

Revision as of 09:41, 8 August 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pha← Previous edit		Revision as of 02:27, 9 August 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_PharmNext edit →
Line 1:		Line 1:
	{{Unreferenced stub\|auto=yes\|date=December 2009}}		{{Unreferenced stub\|auto=yes\|date=December 2009}}
	{{drugbox		{{drugbox
		⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
	\| Verifiedfields = changed
⚫	\| UNII_Ref = {{fdacite\|~~changed~~\|FDA}}
	\| UNII = 230447L0GL		\| UNII = 230447L0GL
	\| verifiedrevid = ~~399925296~~		\| verifiedrevid = 443652033
	\|		\|
	\| drug_name = Etiracetam		\| drug_name = Etiracetam

Revision as of 02:27, 9 August 2011

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Etiracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Etiracetam
Clinical data


Routes of administration	Oral
ATC code	none
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name (RS)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS Number	33996-58-6
PubChem CID	59708
ChemSpider	53863
UNII	230447L0GL
CompTox Dashboard (EPA)	DTXSID5046510
ECHA InfoCard	100.111.445
Chemical and physical data
Formula	C₈H₁₄N₂O₂
Molar mass	170.209 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES CCC(C(=O)N)N1CCCC1=O
InChI InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) Key:HPHUVLMMVZITSG-UHFFFAOYSA-N
(verify)

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.